Sitagliptin Alpha Tablet 25mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.
MFDS item code 202004069 · Approved 2020.05.29
This product's status changed to Approval withdrawn on 2024.09.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to assist patients with type 2 diabetes who find it difficult to control blood glucose levels with diet and exercise alone. Initially, it can be administered as monotherapy, and if blood glucose is not well controlled with other antidiabetic medications, it may be used in combination with metformin, sulfonylureas, thiazolidinediones, insulin, and others. When multiple therapeutic approaches do not sufficiently control blood glucose, this medication can be added to improve blood sugar levels. Thus, it is used effectively at various treatment stages to control blood glucose.
This drug is administered once daily at a dose of 100 mg as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This drug may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see section 5. General Precautions, under Precautions for Use). Patients with renal impairment Since dosage adjustment is required according to renal function, evaluation of renal function is recommended before treatment with this drug and periodically thereafter. 1. No dosage adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. In patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This drug may be administered regardless of the timing of dialysis.
This medication can cause severe allergic reactions, so if symptoms such as rash or difficulty breathing occur, use should be stopped immediately, and a doctor should be consulted. Additionally, serious side effects such as pancreatitis, which is inflammation of the pancreas, have been reported. If symptoms such as abdominal pain or vomiting occur, it is important to inform medical personnel immediately. This medication should not be used in patients with type 1 diabetes or severe renal impairment. Patients with reduced kidney function need to adjust the dosage of this medication, so it should be taken according to a doctor's instructions. During treatment with this medication, side effects such as infections, headaches, dyspepsia, and diarrhea may occur. If symptoms persist or worsen, consult a physician. Using other blood glucose-lowering agents, especially in combination with insulin or sulfonylureas, may increase the risk of hypoglycemia, so blood glucose levels should be closely monitored. Severe joint pain or blistering skin diseases may occur, so if such symptoms arise, inform the doctor immediately. Pregnant or breastfeeding women are advised to avoid using this medication, and safety and efficacy have not been established in children under 18 years of age. Elderly patients may have reduced kidney function, so it is recommended to have kidney function tests before and after taking this medication. In cases of overdose, general emergency measures should be taken, and if necessary, dialysis can help remove some of this medication. This medication has relatively few drug interactions, but the concentration may change when used in combination with certain medications, so be sure to inform your doctor or pharmacist about any medicines being taken.
Severe allergic reaction, anaphylaxis, angioedema, Stevens-Johnson syndrome, exfoliative skin disease, acute pancreatitis, hypoglycemia, nasopharyngitis, upper respiratory infection, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, severe arthralgia accompanied by disability, blistering dermatitis herpetiformis, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevated liver enzymes, acute renal failure, worsening renal function, rash, urticaria, cutaneous vasculitis, pneumonia, diabetes complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased ALT, increased AST, elevated serum triglycerides, gastritis, peripheral edema, weight loss, hypertension, hypernatremia, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that protects it from air and kept at room temperature between 1 and 30 degrees Celsius. Proper storage can maintain the medication's effectiveness and prevent degradation.
Pink, round, biconvex film-coated tablet
28 tablets/box [14 tablets/PTP×2], 30 tablets/box [10 tablets/PTP×3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.